Zydus Lifesciences Q1 Results
- BSE: 532321
- NSE: ZYDUSLIFE
- ISIN: INE010B01027
- Sector: Biotechnology & Drugs
BSE
1,113.05
7.30 (0.66%)
7.30 (0.66%)Volume55.28 K
Updated: Wed 10 Jun, 2026 | 12:08:23
NSE
1,115.7010.10 (0.91%)
10.10 (0.91%)Volume3.09 L
Updated: Wed 10 Jun, 2026 | 11:53:25
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Zydus Lifesciences Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 4,780.40 | 6,583.40 | -0.83% | 4,313.60 | 10.82% |
| Depreciation/ Amortization | 238.10 | 508.40 | 0.08% | 215.30 | 10.59% |
| Operating Income | 1,793.30 | 1,003.60 | 5.03% | 1,893.90 | -5.31% |
| Net Income | 1,466.80 | 1,272.50 | 25.27% | 1,419.90 | 3.30% |
| Other Operating Expenses Total | 1,747.60 | 2,462.40 | 3.13% | 1,628.70 | 7.30% |
| Net Income Before Taxes | 1,920.60 | 1,659.70 | 14.87% | 1,899.70 | 1.10% |
| Total Revenue | 6,573.70 | 7,587.00 | 0.70% | 6,207.50 | 5.90% |
| Selling/ General/ Admin Expenses Total | 1,005.20 | 1,238.80 | 3.48% | 883.50 | 13.77% |
| Diluted Normalized EPS | 14.58 | 15.84 | 9.92% | 14.11 | 3.33% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.